Jack Phillips - Feb 13, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Executive Officer
Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Feb 13, 2023
Transactions value $
-$5,161
Form type
4
Date filed
2/15/2023, 05:30 PM
Previous filing
Feb 1, 2023
Next filing
Mar 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +17.2K +6.6% $0.00 278K Feb 13, 2023 Direct F1
transaction AXDX Common Stock Sale -$5.16K -8.6K -3.09% $0.60 269K Feb 13, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Award $0 +350K $0.00 350K Feb 13, 2023 Common Stock 350K Direct F3, F4, F5
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -17.2K -100% $0.00* 0 Feb 13, 2023 Common Stock 17.2K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4 The reporting person received restricted stock units on February 13, 2023, which will vest on March 8, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F5 Not Applicable.